These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18092892)
1. Out FOXing Parkinson disease: where development meets neurodegeneration. Wexler EM; Geschwind DH PLoS Biol; 2007 Dec; 5(12):e334. PubMed ID: 18092892 [TBL] [Abstract][Full Text] [Related]
2. Tau-induced neurodegeneration: a clue to its mechanism. del C Alonso A; Iqbal K J Alzheimers Dis; 2005 Dec; 8(3):223-6. PubMed ID: 16340080 [No Abstract] [Full Text] [Related]
3. Structural neurology: are seeds at the root of neuronal degeneration? Lansbury PT Neuron; 1997 Dec; 19(6):1151-4. PubMed ID: 9427238 [No Abstract] [Full Text] [Related]
4. Deciphering the role of VPS35 in Parkinson's disease. Williams ET; Moore DJ J Neurosci Res; 2018 Aug; 96(8):1339-1340. PubMed ID: 29775219 [No Abstract] [Full Text] [Related]
5. Neural degeneration in Parkinson's disease. Riederer P; Reichmann H; Janetzky B; Sian J; Lesch KP; Lange KW; Double KL; Nagatsu T; Gerlach M Adv Neurol; 2001; 86():125-36. PubMed ID: 11553969 [No Abstract] [Full Text] [Related]
6. Parkinson disease: from pathology to molecular disease mechanisms. Dexter DT; Jenner P Free Radic Biol Med; 2013 Sep; 62():132-144. PubMed ID: 23380027 [TBL] [Abstract][Full Text] [Related]
7. The importance of choosing a preclinical model that reflects what happens in Parkinson's disease. Segura-Aguilar J Neurochem Int; 2019 Jun; 126():203-209. PubMed ID: 30922924 [TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433 [TBL] [Abstract][Full Text] [Related]
9. Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Bayersdorfer F; Voigt A; Schneuwly S; Botella JA Neurobiol Dis; 2010 Oct; 40(1):113-9. PubMed ID: 20211259 [TBL] [Abstract][Full Text] [Related]
10. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512 [TBL] [Abstract][Full Text] [Related]
11. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders. Krüger R; Müller T; Riess O J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401 [TBL] [Abstract][Full Text] [Related]
13. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging. Volovik Y; Marques FC; Cohen E Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346 [TBL] [Abstract][Full Text] [Related]
14. Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease. Uhl GR Ann Neurol; 1998 May; 43(5):555-60. PubMed ID: 9585349 [No Abstract] [Full Text] [Related]
15. Is alpha-synuclein the culprit of the Parkinsonian neurodegeneration? Kirik D; Gai WP; Jensen PH Exp Neurol; 2008 Jan; 209(1):3-4. PubMed ID: 18179907 [No Abstract] [Full Text] [Related]
16. Many forkheads in the road to regulation. Symposium on forkhead transcription factor networks in development, signalling and disease. Cirillo LA; Barton MC EMBO Rep; 2008 Aug; 9(8):721-4. PubMed ID: 18617889 [No Abstract] [Full Text] [Related]
17. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease. Kazantsev AG; Kolchinsky AM Arch Neurol; 2008 Dec; 65(12):1577-81. PubMed ID: 19064744 [TBL] [Abstract][Full Text] [Related]
18. PINK1/Parkin mitophagy and neurodegeneration-what do we really know in vivo? Whitworth AJ; Pallanck LJ Curr Opin Genet Dev; 2017 Jun; 44():47-53. PubMed ID: 28213158 [TBL] [Abstract][Full Text] [Related]
19. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Liu B; Dluzen DE Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209 [TBL] [Abstract][Full Text] [Related]
20. Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease. Gasmi M; Herzog CD; Brandon EP; Cunningham JJ; Ramirez GA; Ketchum ET; Bartus RT Mol Ther; 2007 Jan; 15(1):62-8. PubMed ID: 17164776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]